Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
+4,700
New +$697K ﹤0.01% 3702

Other funds holding ACLS

John Overdeck's ACLS Position: Q2 2026 in Review

John Overdeck reduced its Axcelis (ACLS) stake by 75% in Q2 2026, selling an estimated $22.1M and leaving 48,437 shares worth $9.18M. The position accounts for 0.01% of the portfolio, ranked #1584.

John Overdeck first reported a position in ACLS in Q2 2013 and has held it in 40 quarters since. The position peaked at $18.4M in Q1 2026. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • John Overdeck held 48,437 shares of Axcelis worth $9.18M as of Q2 2026.
  • John Overdeck sold 149,129 Axcelis shares in Q2 2026, an estimated $22.1M.
  • Axcelis made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1584 holding.
  • John Overdeck first reported a position in Axcelis in Q2 2013 and has held it in 40 quarters since.
  • John Overdeck's Axcelis position peaked at $18.4M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.